The company was established in 2008 and was co-founded by Dr. Karl Tryggvason and his son Dr. Kristian Tryggvason. Today the company has about 20 employees spanning from production, R&D, logistics, sales and marketing. Our quality system complies with ISO 9001:2015 and both management and employees follow well-defined standard processes and agreements.
BioLamina’s Biolaminins™ are the only original full length, human, recombinant laminin cell culture substrates on the market. We are known and recognized for our premium products, competence, dedication and service and position ourselves as being in the forefront of cell culturing. Our high technology products contribute to our customer’s efficiency and scientific breakthroughs and enable them to start a new era in medical research. We offer an expansive portfolio of chemically defined and xeno-free laminin proteins for a variety of applications, including reliable expansion of pluripotent cell and differentiation and maintenance of specialized cell types, such as hepatocytes, skeletal muscle cells and different neural cells. The impact of our Biolaminin matrices on cell culture quality has been scientifically validated in many high-impact journals.
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.